R2's ImageChecker CAD Unanimously Endorsed By Radiology Panel
This article was originally published in The Gray Sheet
R2 Technology's ImageChecker M1000 could identify and mark for further review 31-44% more potentially positive mammograms than would currently be identified, William Sacks, a medical officer in FDA's Office of Device Evaluation, said at a Radiological Devices Advisory Panel meeting in Rockville, Maryland.
You may also be interested in...
Fischer Imaging's premarket notification submission for the SenoScan full-field digital mammography system is readily convertible into a PMA, should FDA reject the 510(k) approach for the device, as the agency has done in the past.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.